Sun Pharmaceutical Industries Limited Open Interest & PCR Analysis
₹1,673.5Updated 21 Apr 2026, 01:26 pm IST
PCR
0.72
Bearish signal
Max Pain
₹1,690
Spot below by ₹17
Total CE OI
7.90M
Call writers
Total PE OI
5.69M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
Data as of 2026-04-18
Related Analysis
Frequently Asked Questions
What is Sun Pharmaceutical Industries Limited PCR (Put-Call Ratio) today?▾
Sun Pharmaceutical Industries Limited's current PCR is 0.72. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Sun Pharmaceutical Industries Limited's PCR of 0.72 indicates bearish sentiment.
What is Sun Pharmaceutical Industries Limited OI buildup type today?▾
Sun Pharmaceutical Industries Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Sun Pharmaceutical Industries Limited?▾
Sun Pharmaceutical Industries Limited has total CE (call) OI of 7896000 contracts and total PE (put) OI of 5692050 contracts for the nearest expiry. The PCR is 0.72.
How is open interest analysis useful for Sun Pharmaceutical Industries Limited trading?▾
OI analysis for Sun Pharmaceutical Industries Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Sun Pharmaceutical Industries Limited?▾
Sun Pharmaceutical Industries Limited's max pain is ₹1,690 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.